Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. - Kastritis, E.; Palladini, G.; Minnema, M. C.; Wechalekar, A. D.; Jaccard, A.; Lee, H. C.; Sanchorawala, V.; Gibbs, S.; Mollee, P.; Venner, C. P.; Lu, J.; Schönland, S.; et al. (New England Journal of Medicine, 2021)